- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/09 - Tumour cells
Patent holdings for IPC class C12N 5/09
Total number of patents in this class: 1637
10-year publication summary
88
|
104
|
126
|
136
|
183
|
179
|
160
|
167
|
177
|
46
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
34 |
Precedo Pharmaceuticals Co., Ltd | 47 |
34 |
Dana-Farber Cancer Institute, Inc. | 2455 |
25 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
18 |
Shandong First Medical University & Shandong Academy of Medical Sciences | 34 |
18 |
The Johns Hopkins University | 5377 |
15 |
Centre National de La Recherche Scientifique | 9632 |
14 |
The Brigham and Women's Hospital, Inc. | 2087 |
12 |
The Trustees of Columbia University in the City of New York | 3440 |
11 |
President and Fellows of Harvard College | 5792 |
10 |
Keio University | 1053 |
10 |
Massachusetts Institute of Technology | 9795 |
9 |
University of South Florida | 1817 |
9 |
Toagosei Co., Ltd. | 894 |
9 |
Duke University | 2872 |
8 |
Industry-Academic Cooperation Foundation, Yonsei University | 2329 |
8 |
Hitachi Chemical Company, Ltd. | 2455 |
7 |
Board of Regents, The University of Texas System | 5370 |
7 |
The General Hospital Corporation | 4517 |
7 |
Mayo Foundation for Medical Education and Research | 2981 |
7 |
Other owners | 1365 |